Deborah M. Messemer Allogene Therapeutics, Inc. (ALLO) insider trading activity

Deborah M. Messemer is Director of Allogene Therapeutics, Inc.. Currently has a direct ownership of 107,431 shares of ALLO, which is worth approximately $152,552. The most recent transaction as insider was on Jun 10, 2025, when has been sold 36,885 shares (Common Stock) at a price of $1.42 per share, resulting in proceeds of $52,376. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 107K

25.56% 3M change

35.58% 12M change

Total Value Held $152,552

DEBORAH M. MESSEMER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 10 2025	SELL Open market or private sale	$52,376 $1.42 p/Share	36,885 Reduced 25.56%	107,431 Common Stock
Feb 18 2025	SELL Open market or private sale	$32,350 $2.43 p/Share	13,313 Reduced 8.45%	144,316 Common Stock
Dec 09 2024	SELL Open market or private sale	$19,916 $2.18 p/Share	9,136 Reduced 5.48%	157,629 Common Stock
Jun 18 2024	SELL Open market or private sale	$42,501 $2.28 p/Share	18,641 Reduced 10.05%	166,765 Common Stock
Jun 05 2024	BUY Grant, award, or other acquisition	-	122,950 Added 39.87%	185,406 Common Stock
Dec 18 2023	SELL Open market or private sale	$50,328 $2.7 p/Share	18,640 Reduced 22.99%	62,456 Common Stock
Jun 13 2023	BUY Grant, award, or other acquisition	-	74,561 Added 47.9%	81,096 Common Stock

Also insider at

PYPL

PayPal Holdings, Inc. Financial Services

Director

TPG

TPG Inc. Financial Services

Director

DMM